NCT04555343 - Intravesical Antifibrinolytic for Patients With Hematuria and Clot Retention | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

September 30, 2021

Study Completion Date

October 30, 2021

Conditions

Urologic DiseasesProstate CancerBladder CancerUrinary RetentionHematuriaNurse Physician RelationsNurse's RolePatient Satisfaction

Interventions

DRUG

Tranexamic acid

1gm instilled instravesically

Trial Locations (2)

Royal Columbian Hospital, New Westminster

Eagle Ridge Hospital, Port Moody